Cortisol, the HPA Axis, and Burnout

Introduction: When Survival Becomes Self-Destruction

The stress response is one of evolution's most elegant achievements. In the presence of a predator, a flooding river, or a hostile encounter, the rapid mobilisation of cortisol provides the metabolic fuel, the immunological readiness, and the cognitive sharpening that the situation demands. The system is designed for brevity — a surge, a resolution, a return to baseline. What evolution did not anticipate was a civilisation in which the threat never resolves: the inbox that never empties, the performance review that never ends, the ambient low-grade alarm of modern professional life.

In my clinical practice, I see this daily. Patients arrive describing a fatigue that sleep does not touch, a mental fog that caffeine no longer lifts, a body that seems to have forgotten how to rest. Their blood work, at first glance, may appear unremarkable. Serum cortisol, drawn at nine in the morning, sits comfortably within the reference range. And yet something is profoundly wrong. The problem is not that the system is overactive — it is that the system has been overactive for so long that it has begun to fail. Understanding that distinction is, I believe, one of the most important things a clinician working at the intersection of stress medicine and longevity can learn.

This article sets out the underlying physiology, the evidence for harm, the tools for measurement, and the interventions that genuinely move the needle — all in service of a single clinical principle: burnout is not a personal failing. It is a physiological state. And physiological states are measurable, modifiable, and addressable.

The HPA Axis: Architecture of the Stress Response

The CRH → ACTH → Cortisol Cascade

The hypothalamic-pituitary-adrenal axis constitutes the principal hormonal arm of the mammalian stress response. In the presence of a stressor — whether physical, immunological, or psychosocial — specialised parvocellular neurons in the paraventricular nucleus (PVN) of the hypothalamus release corticotropin-releasing hormone (CRH) into the hypophyseal portal circulation. CRH binds to CRH-R1 receptors on anterior pituitary corticotrophs, stimulating the synthesis and cleavage of pro-opiomelanocortin (POMC) into adrenocorticotropic hormone (ACTH) [5]. ACTH is released into the systemic circulation, where it acts on melanocortin type 2 receptors (MC2R) on zona fasciculata cells of the adrenal cortex, triggering a rapid and dose-dependent secretion of cortisol.

Cortisol exerts its effects through two intracellular receptor systems: the high-affinity mineralocorticoid receptor (MR), which is nearly fully occupied even at basal cortisol concentrations, and the lower-affinity glucocorticoid receptor (GR), which is progressively recruited as cortisol levels rise with stress or circadian peak [6]. This dual receptor architecture means that the body interprets the magnitude of cortisol signal differently depending on context — a nuance that has significant implications for understanding HPA dysregulation.

Negative Feedback and Regulatory Homeostasis

The cascade is self-limiting through a multi-level negative feedback system. Cortisol binds GR in the hippocampus, prefrontal cortex, hypothalamus, and anterior pituitary, suppressing both CRH and ACTH release and thereby completing a classic endocrine feedback loop [5]. The hippocampus is particularly rich in both MR and GR receptors, making it exquisitely sensitive to cortisol — and, as we shall see, exquisitely vulnerable to cortisol excess. Integrity of this feedback mechanism is the difference between a stress response that resolves and one that perpetuates itself.

The Circadian Rhythm of Cortisol

In the absence of acute stress, cortisol secretion follows a robust circadian pattern entrained by the suprachiasmatic nucleus (SCN) of the hypothalamus and synchronised with the light-dark cycle. Cortisol is lowest between midnight and approximately 3:00 AM, then rises sharply in the hour following awakening — a phenomenon termed the cortisol awakening response (CAR) — reaching its peak typically between 30 and 45 minutes after waking [7]. It then declines progressively through the day, reaching a nadir in the late evening. This diurnal architecture serves critical functions: the morning peak mobilises glucose for the day ahead, promotes alertness and immune readiness, and suppresses overnight inflammatory activity. The evening nadir permits tissue repair, growth hormone secretion, and the immunological processes that depend on glucocorticoid withdrawal. Disruption of this rhythm — in either direction — carries measurable biological cost.

Chronic Stress and HPA Dysregulation

Allostatic Load: The Cumulative Cost of Repeated Activation

Bruce McEwen's foundational concept of allostatic load, introduced in a landmark 1998 paper in the New England Journal of Medicine, reframed how medicine understands stress-related disease [2]. Allostasis — from the Greek allos (variable) and stasis (stability) — describes the body's ability to achieve stability through change. Unlike homeostasis, which implies a fixed set point, allostasis acknowledges that the body's internal environment shifts adaptively in response to demand. Allostatic load, then, is the accumulated biological cost of this repeated shifting: the wear and tear on regulatory systems that have been mobilised too often, for too long, without adequate recovery.

McEwen identified four patterns of allostatic load relevant to the HPA axis: (1) repeated or prolonged stress exposure driving persistent elevation in cortisol; (2) failure to habituate to repeated stressors; (3) inability to shut down the stress response once the stressor has passed; and (4) inadequate stress response requiring compensation by other systems [2]. Each pattern produces distinct but overlapping patterns of organ damage, spanning the cardiovascular, metabolic, immune, and neurological systems.

The Paradox of Burnout: Blunted Cortisol in a Depleted System

A common misconception — one that leads to significant diagnostic confusion — is the assumption that burnout is characterised by chronically elevated cortisol. In fact, the neuroendocrinology of established burnout is considerably more nuanced. Pruessner and colleagues, in a seminal 1999 study published in Psychoneuroendocrinology, demonstrated that teachers experiencing high levels of burnout showed a markedly blunted cortisol awakening response compared with non-burned-out controls — a pattern diametrically opposite to the heightened CAR observed in early or acute stress states [3].

This finding reflects a stage-dependent model of HPA dysregulation. In the early phase of chronic stress, cortisol output tends to be elevated — the system is working harder to meet demand. With prolonged, unresolved stress, however, the regulatory architecture begins to fail: GR sensitivity decreases, negative feedback becomes less effective in some pathways while other compensatory mechanisms attempt to brake an overactive system, and eventually the adrenal output itself becomes insufficient to meet demand. The result is a flattened diurnal cortisol curve — neither the morning peak nor the evening trough is where it should be — and a blunted awakening response that leaves individuals feeling unrefreshed, cognitively sluggish, and unable to generate the motivational momentum needed to begin the day [3, 7].

Hyperactive Versus Hypoactive HPA: A Spectrum, Not a Binary

Clinically, it is essential to understand that HPA dysregulation exists on a spectrum. The same individual may demonstrate periods of hyperactivation — characterised by elevated waking cortisol, night-time arousal, and anxiety — interleaved with phases of relative hypoactivation — characterised by profound morning fatigue, low motivation, and cognitive blunting. This temporal heterogeneity is precisely why single-point blood cortisol measurements are so diagnostically inadequate. The number drawn at 9 AM on a Tuesday tells us very little about the architecture of cortisol secretion over a 24-hour period — or over the preceding months.

Burnout as a Physiological State: The ICD-11 Framework

In May 2019, the World Health Organisation formally classified burnout in the 11th revision of the International Classification of Diseases (ICD-11, code QD85), defining it as "a syndrome conceptualised as resulting from chronic workplace stress that has not been successfully managed" [9]. The WHO characterised burnout through three dimensions: (1) feelings of energy depletion or exhaustion; (2) increased mental distance from one's job, or feelings of negativism or cynicism related to one's job; and (3) reduced professional efficacy.

Crucially, the WHO classification positions burnout not as a medical condition per se but as a syndrome arising from an occupational context — a distinction with important clinical and societal implications. It legitimises the physiological reality of burnout while anchoring it in the domain of work-life experience rather than individual pathology. For the patient sitting across from me in clinic, this framing matters enormously. I often observe a profound sense of shame in people who have burned out — a belief that they have somehow failed, that they are insufficiently resilient, that stronger people manage these same demands without collapse. The ICD-11 classification, and the physiology behind it, offers a different narrative: your nervous system responded, entirely predictably, to conditions it was not designed to sustain indefinitely.

What the ICD-11 classification does not yet fully reflect — though the underlying science demands it — is the extent to which burnout is a measurable neuroendocrine state with consequences that extend far beyond occupational function. The telomeres are shortening. The hippocampus is atrophying. The insulin sensitivity is declining. Burnout, left unaddressed, is not simply a problem for productivity. It is a problem for biological age.

What Chronic Cortisol Does to the Body

Telomere Shortening and Accelerated Cellular Ageing

Perhaps the most striking evidence linking chronic stress to accelerated biological ageing comes from the work of Elissa Epel and colleagues, published in the Proceedings of the National Academy of Sciences in 2004 [1]. In a study of 58 premenopausal women — comparing mothers of chronically ill children (high-stress group) with mothers of healthy children (low-stress group) — the researchers measured telomere length in peripheral blood mononuclear cells, telomerase activity, and oxidative stress markers.

The findings were striking. Women in the highest perceived-stress group had telomeres that were, on average, equivalent to those of women approximately ten years older in the low-stress group. Telomerase activity was significantly lower in the high-stress group. Oxidative stress markers were elevated. The authors calculated that the difference in telomere length between the highest- and lowest-stress tertiles corresponded to between 9 and 17 years of additional biological ageing [1]. This was not a trivial effect in a trivially stressful situation — it was a measurable acceleration of cellular senescence in women doing something as profoundly human as caring for an ill child.

The mechanism is multifactorial. Cortisol increases reactive oxygen species (ROS) production and reduces antioxidant defences, promoting oxidative stress at the telomere. Glucocorticoids also suppress telomerase activity directly, reducing the capacity to maintain telomere length against the attrition of each cell division [1, 10]. Additionally, cortisol-driven alterations in immune cell populations — particularly reductions in naive T cells and increases in highly differentiated, telomere-shortened effector T cells — skew the peripheral lymphocyte pool towards an immunosenescent phenotype.

Hippocampal Atrophy and Cognitive Consequences

The hippocampus — critical for episodic memory consolidation, spatial navigation, and contextual fear extinction — is among the most cortisol-sensitive structures in the brain. It expresses the highest density of GR in the central nervous system, and while it depends on pulsatile, appropriately-timed cortisol signalling for synaptic plasticity and memory encoding, it is profoundly damaged by sustained glucocorticoid excess [6]. Animal studies consistently demonstrate dendritic atrophy in CA3 pyramidal neurons, reduced neurogenesis in the dentate gyrus, and eventual hippocampal volume loss following chronic corticosterone exposure. Human neuroimaging studies show comparable findings: individuals with post-traumatic stress disorder, major depression with hypercortisolaemia, and Cushing's syndrome all demonstrate significant reductions in hippocampal volume, with corresponding impairments in declarative memory and emotional regulation [11].

In the context of burnout — even in individuals who do not meet criteria for clinical depression — subtle hippocampal changes are observed. The cognitive symptoms of burnout (difficulty concentrating, impaired working memory, word-finding difficulties, a sense that information is not "sticking") almost certainly reflect, in part, glucocorticoid-mediated interference with hippocampal function. Critically, these changes appear to be partially reversible with stress reduction and cortisol normalisation — a finding with significant clinical optimism.

Immune Suppression and the Dhabhar Paradox

The relationship between cortisol and immune function is contextual, dose-dependent, and chronologically staged — a complexity elegantly described by Firdaus Dhabhar in a 2014 review in Immunological Research [4]. Acute, brief stress — the evolutionary archetype — actually enhances immune readiness: cortisol and catecholamines mobilise immune cells from the bone marrow and secondary lymphoid organs, redistribute them to peripheral tissues (skin, lymph nodes, mucosal surfaces), and prime innate immune cells for rapid pathogen recognition. This is a survival advantage in the context of a physical threat.

Chronic stress reverses this advantage. Sustained glucocorticoid exposure suppresses both innate and adaptive immune responses: natural killer cell cytotoxicity is reduced, T-helper 1 (Th1) cytokine production is suppressed (impairing cellular immunity), secretory IgA at mucosal surfaces declines (increasing susceptibility to upper respiratory infections), and regulatory T cell function is altered in ways that paradoxically increase inflammatory activity in some tissue compartments [4]. The net result is an immune system simultaneously less effective at defending against infection and neoplastic transformation, and more prone to low-grade chronic inflammation — the latter being a major driver of age-related disease across cardiovascular, metabolic, and neurological domains.

Metabolic Dysregulation: Visceral Fat and Insulin Resistance

Cortisol's metabolic effects are profound and, at clinical concentrations associated with chronic stress, profoundly harmful. Glucocorticoids promote adipogenesis in visceral (omental and mesenteric) fat depots, which are enriched in 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) — an enzyme that locally amplifies cortisol activity by converting inactive cortisone back to active cortisol [12]. This creates a self-amplifying cycle: central adiposity drives local cortisol regeneration, which drives further visceral fat deposition, irrespective of circulating cortisol concentrations. The result is the characteristic stress-related metabolic phenotype: central obesity, dyslipidaemia (elevated triglycerides, reduced HDL), and progressive insulin resistance.

Cortisol induces insulin resistance through multiple mechanisms: by promoting hepatic gluconeogenesis (increasing glucose output), by reducing GLUT4 transporter translocation in peripheral tissues (reducing glucose uptake), and by antagonising insulin signalling cascades at the level of the insulin receptor substrate (IRS) proteins [12]. In chronically stressed individuals, fasting glucose and insulin levels may remain within "normal" laboratory ranges for years while tissue-level insulin sensitivity deteriorates — a gap that standard metabolic screening largely misses, and that fasting insulin and HOMA-IR calculations can begin to reveal.

Cardiovascular Risk

The cardiovascular consequences of chronic HPA activation operate through both direct and indirect pathways. Directly, glucocorticoids increase cardiac output, enhance vascular smooth muscle sensitivity to vasoconstrictors, and promote sodium retention — collectively elevating blood pressure [2]. Indirectly, the pro-inflammatory, pro-thrombotic, and metabolic sequelae of chronic cortisol excess (elevated fibrinogen, increased platelet aggregability, dyslipidaemia, insulin resistance) collectively amplify atherosclerotic risk. Population-level data consistently show that individuals with high perceived stress, high allostatic load scores, or objective measures of HPA dysregulation carry significantly elevated risk of myocardial infarction, stroke, and sudden cardiac death — risks that persist after adjustment for traditional cardiovascular risk factors [2, 8].

The Burnout-Longevity Connection: Evidence and Implications

The convergence of the above evidence lines creates a coherent and troubling picture. Burnout — characterised by HPA dysregulation, blunted cortisol awakening response, and elevated perceived stress — imposes biological consequences that are not merely symptomatic but structural and progressive. Telomeres shorten. Hippocampal volume decreases. Visceral fat accumulates. Insulin resistance develops. The inflammatory milieu shifts towards the chronic low-grade activation that underlies nearly every major age-related pathology.

McEwen's allostatic load framework provides a unifying model: the cumulative physiological cost of repeated HPA activation is not merely the sum of individual stressor responses, but an emergent biological state in which multiple regulatory systems have been simultaneously degraded [2]. High allostatic load scores — composite indices incorporating cortisol, DHEA-S, norepinephrine, epinephrine, blood pressure, waist-hip ratio, HDL, total cholesterol, HbA1c, and C-reactive protein — have been consistently associated with increased all-cause mortality, cognitive decline, and functional deterioration in multiple longitudinal cohort studies [2, 13].

The Epel telomere data place a concrete number on the cost: up to ten additional years of biological ageing attributable to chronic psychological stress [1]. For a longevity medicine perspective, this is not an abstraction — it is a concrete measurable target. If biological age can be accelerated by chronic stress, it can also, with appropriate intervention, be decelerated.

Measuring the HPA Axis: Beyond the Morning Blood Draw

Why Standard Serum Cortisol Misses the Picture

The conventional investigation of suspected HPA dysfunction — a single early-morning serum cortisol measurement — is designed to screen for extreme pathological states: Addison's disease at one end, Cushing's syndrome at the other. It is entirely inadequate for the assessment of the functional HPA dysregulation that underlies burnout, chronic stress, and the associated acceleration of biological ageing. A 9 AM serum cortisol of 450 nmol/L tells a clinician that the adrenal gland is not in crisis. It tells them nothing about the cortisol awakening response, the afternoon decline, the evening nadir, the nocturnal baseline, or the DHEA-S:cortisol ratio — all of which are clinically essential.

Serum cortisol also reflects total (bound plus free) hormone, whereas only the free fraction is biologically active. Cortisol-binding globulin (CBG) concentrations vary significantly between individuals and can be influenced by oestrogen status, inflammation, and liver function — all of which may be perturbed in chronically stressed patients, making total cortisol an unreliable proxy for bioavailable hormone.

Four-Point Salivary Cortisol Profiling

The assessment standard I use at Longyx, and which I regard as the minimum clinically meaningful investigation for HPA function, is a four-point salivary cortisol profile: samples collected at waking (time zero), 30–45 minutes post-waking (to capture the cortisol awakening response), noon, and 10–11 PM [7]. Salivary cortisol reflects free, bioavailable cortisol with high fidelity and excellent correlation with cerebrospinal fluid cortisol, without the confound of CBG variation. Collection occurs in the patient's natural environment on a typical day — a critical advantage over laboratory-based measurements, which are reliably distorted by the stress of venepuncture and clinical settings.

From this four-point profile, the clinician can assess: the magnitude and timing of the CAR; the gradient of the diurnal decline; the adequacy of the evening nadir; and the shape of the overall diurnal curve. A blunted CAR (peak less than two-to-threefold above waking baseline) suggests HPA under-activation consistent with established burnout. An elevated evening cortisol (above approximately 3–4 nmol/L in saliva) suggests diurnal rhythm flattening and is associated with sleep disruption, mood dysregulation, and immune compromise.

DHEA-S:Cortisol Ratio

Dehydroepiandrosterone sulphate (DHEA-S), the adrenal androgen precursor, is co-secreted with cortisol under ACTH stimulation but follows an independent age-related decline beginning in the third decade. In the context of chronic stress, DHEA-S and cortisol frequently diverge: cortisol remains elevated or dysregulated while DHEA-S declines — a shift that progressively increases the cortisol:DHEA-S ratio. This ratio is a sensitive composite biomarker of adrenocortical stress burden. An elevated ratio (reflecting DHEA-S insufficiency relative to cortisol) is associated with immune senescence, sarcopenia, cognitive decline, depressed mood, and reduced resilience to subsequent stressors [14]. Assessing this ratio provides substantially more clinical information than either biomarker alone.

The DUTCH Test: Comprehensive Urinary Steroid Metabolite Profiling

For the most clinically complete picture of HPA function, I use the DUTCH (Dried Urine Test for Comprehensive Hormones) test, which profiles urinary steroid hormone metabolites — including cortisol, cortisone, and their principal metabolic products — across a 24-hour period using dried urine samples collected at waking, before bed, and at two points overnight. The DUTCH test provides information that neither serum nor salivary testing can offer: it captures total daily cortisol production (integrated 24-hour output, not merely peak or nadir values); it distinguishes between impaired cortisol clearance and impaired production (both can present with low free cortisol); and it assesses the relative activity of 11β-HSD1 and 11β-HSD2 — the enzymes that interconvert active cortisol and inactive cortisone at the tissue level [15].

This degree of resolution matters clinically. Two patients with identical four-point salivary cortisol profiles may have entirely different underlying mechanisms — and therefore require different interventions. One may have low adrenal cortisol output; the other may have normal output but dramatically accelerated clearance. The DUTCH test distinguishes these states.

Interventions That Actually Work

Sleep: The Most Powerful HPA Reset Tool Available

Sleep is not merely a passive state of rest; it is an active process of neuroendocrine restoration. The overnight period — particularly the first half, dominated by slow-wave (N3) sleep — is when growth hormone is pulsatilely secreted, when cortisol reaches its nadir, and when the hypothalamic regulatory neurons recover from the previous day's allostatic demands. Sleep deprivation — even moderate restriction to six hours per night over two weeks — significantly elevates basal cortisol and blunts the cortisol awakening response, mimicking and reinforcing the neuroendocrine profile of burnout [16]. Sleep extension and sleep quality optimisation (addressing sleep architecture, circadian alignment, and sleep hygiene) are therefore not supplementary wellness recommendations — they are primary neuroendocrine interventions.

In practice, I prioritise sleep assessment — using actigraphy where appropriate — before any pharmacological or nutraceutical intervention. Prescribing an adaptogen to a patient who is sleeping five hours a night is an expensive and largely futile exercise. The substrate on which every intervention acts is the overnight recovery window.

Heart Rate Variability Biofeedback

Heart rate variability (HRV) — the beat-to-beat variation in cardiac cycle length — reflects the dynamic balance between sympathetic and parasympathetic autonomic inputs to the sinoatrial node. High HRV indicates robust vagal tone, effective stress buffering, and intact HPA regulatory capacity. Low HRV is a consistent finding in burnout, chronic stress, and depression, and is an independent predictor of all-cause cardiovascular mortality [17]. HRV biofeedback training — in which patients practise paced breathing (typically at a resonance frequency of 0.1 Hz, approximately 6 breaths per minute) while observing real-time HRV feedback — has been shown in multiple randomised controlled trials to increase resting HRV, reduce salivary cortisol, improve emotional regulation, and reduce burnout scores [17]. The protocol requires approximately 20 minutes of daily practice for a minimum of four to six weeks to produce durable changes in autonomic baseline.

Ashwagandha (Withania somnifera): The Evidence Base

Among the herbal adaptogens with published randomised controlled trial data, ashwagandha (Withania somnifera), and specifically the concentrated KSM-66 root extract, has the most robust evidence base for HPA modulation. Chandrasekhar and colleagues, in a double-blind, randomised, placebo-controlled trial published in the Indian Journal of Psychological Medicine in 2012, randomised 64 adults with a history of chronic stress to either 300 mg KSM-66 twice daily or placebo for 60 days [18]. The ashwagandha group demonstrated statistically significant reductions in perceived stress scores (PSS), serum cortisol (a 27.9% reduction from baseline versus 7.9% in the placebo group), anxiety (Hamilton Anxiety Rating Scale), and fatigue — alongside significant improvements in general health, sleep quality, social functioning, and quality of life [18].

The mechanisms underlying these effects include modulation of the stress-signalling cascade at multiple levels: withaferin A and withanolides (the principal bioactive compounds) appear to modulate NF-κB signalling, reduce Hsp70 and cortisol biosynthesis pathway activity, and exert GABA-mimetic effects at inhibitory interneurons that modulate CRH neuron activity [19]. Importantly, ashwagandha does not appear to suppress the acute stress response — it appears to improve the regulatory efficiency of the HPA axis rather than simply blunting cortisol output. This is the distinction between an adaptogen and a suppressant, and it matters clinically.

Phosphatidylserine: Cortisol Buffering at the Pituitary Level

Phosphatidylserine (PS), a phospholipid component of neuronal cell membranes, has demonstrated consistent cortisol-buffering effects in human trials, particularly in the context of exercise-induced HPA activation. The proposed mechanism involves attenuation of ACTH secretion at the pituitary — effectively blunting the mid-cascade amplification step without preventing the downstream cortisol response from occurring if the signal is sufficiently strong [20]. Clinical trials using 400–800 mg per day of bovine-derived or soy-derived PS have shown reductions in post-exercise cortisol of 20–30% and improvements in cortisol:DHEA-S ratio [20]. PS is therefore a useful adjunct in individuals with demonstrably elevated cortisol output — particularly where the primary driver appears to be excessive ACTH signalling — and is well-tolerated with a strong safety profile.

What Does Not Work (Or What the Evidence Does Not Support)

A clinical note on interventions that are commonly promoted but poorly supported: generic "adrenal support" supplement complexes without validated cortisol-modulating mechanisms; high-dose vitamin C as a primary HPA intervention (marginal effect sizes in the available literature); and, critically, addressing burnout through productivity optimisation alone. No time-management system corrects a dysregulated HPA axis. The biology does not respond to improved scheduling.

The Longyx Clinical Approach: Measure First. Advise Second.

The animating principle of what we do at Longyx is deceptively simple: we measure before we advise. This is, in my experience, rarer than it should be. The standard clinical encounter — even in progressive integrative medicine settings — too often proceeds from symptom to supplement, from complaint to protocol, without the intermediate step of actually quantifying the biology in that specific individual at that specific moment.

For HPA assessment, this means that every patient presenting with fatigue, burnout, cognitive dysfunction, sleep disruption, or metabolic dysregulation receives a structured neuroendocrine workup: a four-point salivary cortisol profile, DHEA-S with cortisol:DHEA-S ratio, fasting insulin and HOMA-IR, hsCRP, and — where the clinical picture warrants it — a DUTCH test for comprehensive steroid metabolite profiling. This is not a protocol built on theoretical frameworks. It is a protocol built on the recognition that HPA dysregulation is heterogeneous, that the same symptom constellation can arise from diametrically opposite neuroendocrine states, and that intervention without measurement is guesswork dressed in clinical language.

Where the data reveal HPA dysregulation, we build an individualised protocol. This may incorporate sleep optimisation, HRV training, ashwagandha at evidence-based doses, phosphatidylserine, targeted dietary modifications to reduce glycaemic load (which directly impacts cortisol secretion), and — where appropriate — consideration of additional hormonal support. We track the same biomarkers at 8–12 weeks to assess objective response. The goal is not symptom management but biological restitution: a cortisol diurnal curve that has returned to its appropriate shape, a DHEA-S:cortisol ratio that has moved towards a physiologically younger value, a telomere length trajectory that has been interrupted.

A Clinical Perspective: Burnout Is Not a Personal Failure

I want to close with something that I tell every patient who sits across from me having burned out — whether they are a 38-year-old consultant who has not taken a proper holiday in four years, a 44-year-old mother who has been running on three and a half hours of consolidated sleep for a decade, or a 51-year-old executive who describes lying in bed at 6 AM, cortisol barely rising, unable to locate the will to begin the day.

Burnout is not a personal failure. It is not evidence of inadequate resilience. It is not a sign that you are weak, or insufficiently grateful, or insufficiently organised, or insufficiently mindful. It is the honest and entirely predictable biological response of a human nervous system that has been asked to sustain allostatic load beyond its regulatory capacity, for longer than its compensatory reserves could support, without the recovery windows that physiology requires.

The HPA axis does not negotiate. It does not care about your career trajectory, your obligations, or your identity as someone who does not give up. It operates according to biology. And biology, in this context, is not cruel — it is honest. The exhaustion is information. The cognitive fog is information. The flat cortisol curve, when we finally measure it, is information. And information, in medicine, is the beginning of resolution.

The research is unambiguous: chronic stress shortens telomeres [1], shrinks hippocampi [11], dysregulates immune function [4], promotes visceral fat and insulin resistance [12], elevates cardiovascular risk [2], and measurably accelerates biological ageing at a cellular level. These are not soft outcomes. They are hard biology. And hard biology responds to hard evidence — to measurement, to targeted intervention, and to the patient, consistent work of restoring the regulatory systems that stress has degraded.

This is what longevity medicine, done properly, looks like. Not the pursuit of eternal youth through unvalidated supplements and aspirational language. But the careful, data-driven, biologically grounded work of understanding what has happened to a person's physiology — and systematically, measurably, addressing it.